Another encouraging announcement.One day RHT will be noticed by...

Another encouraging announcement.

One day RHT will be noticed by more investors - particularly when dividends come in.

With world wide patents (and patients linked by software) RHT has the potential to be another Cochlier.

I am glad I am in at a cheap price.

IMHO this time next year it will be double the shareprice.
I wait to be corrected.

Today's announcement encourages me to think this way.

You decide if I am ramping or not - I am not a day trader - I'm in for the long haul.

ANNOUNCEMENT 10th Feb 2006 2.10pm

Resonance Health Gains TGA and CE Marking Full Quality Assurance System Approval Certificates

Key points:
• Completed milestone in obtaining Certificates
• Reduction in costs combined with greater flexibility in software and process development
Resonance Health Limited (ASX: RHT) announced today that its wholly-owned subsidiary, Resonance Health Analysis Services Pty Ltd, has been issued Therapeutic Goods Administration (TGA) of Australia and European CE Marking Full Quality Assurance System Approval Certificates.
These new certifications will replace the existing requirements to obtain TGA and CE Mark clearance for each version of the FerriScan® analysis software and each individual batch of FerriScan Phantom Packs (used for the verification of Magnetic Resonance Imaging scanners for FerriScan analysis). The benefits include both a reduction in resources (as a result of not having to apply for multiple assessments) and also a greater flexibility in software and process development.
FerriScan has previously been listed on the Australian Register of Therapeutic Goods (ARTG) by the TGA, has been granted the European CE Mark, and has been granted marketing clearance in the US by the Food and Drug Administration (FDA).

Further Information:
About Resonance Health Ltd
Resonance Health (ASX: RHT) is an Australian Healthcare company specialising in the development and commercialisation of magnetic resonance imaging (MRI)-related technology for the quantitative measurement of iron levels in the human body. Our mission is to develop and market our technologies to assist in the diagnosis and management of patients suffering from iron-related conditions, whilst delivering significant added value for our MRI customers who deliver our service through their networks.